Table 4 Co-interventions during follow-up
Timepoints | IFX Group n=18 | Placebo group n=17 | Total n=35 |
|---|---|---|---|
Analgesics | |||
Day 0 | 14 (77.8) | 15 (88.2) | 29 (82.9) |
Day 10 | 14 (77.9) | 16 (94.1) | 30 (85.7) |
Day 30 | 15 (83.3) | 16 (94.1) | 31 (88.6) |
Day 90 | 14 (77.8) | 16 (94.1) | 30 (85.7) |
Day 180 | 15 (83.3) | 15 (88.2) | 30 (85.7) |
Non-steroidal anti-inflammatory drugs | |||
Day 0 | 5 (27.8) | 5 (29.4) | 10 (28.6) |
Day 10 | 5 (27.8) | 7 (41.2) | 12 (34.3) |
Day 30 | 5 (27.8 | 6 (35.3) | 11 (31.4) |
Day 90 | 6 (33.3) | 6 (35.3) | 12 (34.3) |
Day 180 | 5 (27.8) | 5 (29.4) | 10 (28.6) |
Corticosteroids | |||
Day 0 | 2 (11.1) | 2 (11.8) | 4 (11.4) |
Day 10 | 2 (11.1) | 2 (11.8) | 4 (11.4) |
Day 30 | 2 (11.1) | 2 (11.8) | 4 (11.4) |
Day 90 | 2 (11.1) | 2 (11.8) | 4 (11.4) |
Day 180 | 2 (11.1) | 2 (11.8) | 4 (11.4) |
Antidepressants | |||
Day 0 | 9 (50.0) | 11 (64.7) | 20 (57.1) |
Day 10 | 11 (61.1) | 12 (70.6) | 23 (65.7) |
Day 30 | 10 (55.6) | 12 (70.6) | 22 (62.9) |
Day 90 | 10 (55.6) | 12 (70.6) | 22 (62.9) |
Day 180 | 9 (50.0) | 11 (64.7) | 20 (57.1) |
Anxiolytics | |||
Day 0 | 3 (16.7) | 3 (17.6) | 6 (17.1) |
Day 10 | 3 (16.7) | 4 (23.5) | 7 (20.0) |
Day 30 | 3 (16.7) | 5 (29.4) | 8 (22.9) |
Day 90 | 3 (16.7) | 4 (23.5) | 7 (20.0) |
Day 180 | 3 (16.7) | 3 (17.6) | 6 (17.1) |
Antiepileptics | |||
Day 0 | 8 (44.4) | 8 (47.1) | 16 (45.7) |
Day 10 | 10 (55.6) | 11 (64.7) | 21 (60.0) |
Day 30 | 10 (55.6) | 10 (58.8) | 20 (57.1) |
Day 90 | 9 (50.0) | 9 (52.9) | 18 (51.4) |
Day 180 | 8 (44.4) | 8 (47.1) | 16 (45.7) |